These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25611258)

  • 1. Dendritic cells and hepatocellular carcinoma.
    Streba LA; Streba CT; Săndulescu L; Vere CC; Mitruţ P; Cotoi BV; Popescu LN; Ion DA
    Rom J Morphol Embryol; 2014; 55(4):1287-93. PubMed ID: 25611258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient generation of highly immunocompetent dendritic cells from peripheral blood of patients with hepatitis C virus-related hepatocellular carcinoma.
    Kitahara M; Mizukoshi E; Nakamoto Y; Mukaida N; Matsushima K; Kaneko S
    Int Immunopharmacol; 2014 Aug; 21(2):346-53. PubMed ID: 24893118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
    Chen Y; Huang A; Gao M; Yan Y; Zhang W
    Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
    Yin XY; Wang L; Lu MD; Li BJ; Huang JF
    Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma.
    Song S; Yuan P; Li P; Wu H; Lu J; Wei W
    Int Immunopharmacol; 2014 Oct; 22(2):392-9. PubMed ID: 25066760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for hepatocellular carcinoma.
    Li S; Yang F; Ren X
    Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
    Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF
    Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
    Sun K; Wang L; Zhang Y
    Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma].
    Cai XY; Qiu SJ; Wu ZQ; Ye SL; Fan J; Zhou J; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):671-5. PubMed ID: 15932729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.
    Ritter M; Ali MY; Grimm CF; Weth R; Mohr L; Bocher WO; Endrulat K; Wedemeyer H; Blum HE; Geissler M
    J Hepatol; 2004 Dec; 41(6):999-1007. PubMed ID: 15582134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
    Hu CE; Gan J; Zhang RD; Cheng YR; Huang GJ
    Scand J Gastroenterol; 2011 Feb; 46(2):156-64. PubMed ID: 20822377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
    González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
    Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of dendritic cells by local ablation of hepatocellular carcinoma.
    Ali MY; Grimm CF; Ritter M; Mohr L; Allgaier HP; Weth R; Bocher WO; Endrulat K; Blum HE; Geissler M
    J Hepatol; 2005 Nov; 43(5):817-22. PubMed ID: 16087270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12.
    Tamaki S; Homma S; Enomoto Y; Komita H; Zeniya M; Ohno T; Toda G
    Clin Immunol; 2005 Dec; 117(3):280-93. PubMed ID: 16246626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice.
    Kayashima H; Toshima T; Okano S; Taketomi A; Harada N; Yamashita Y; Tomita Y; Shirabe K; Maehara Y
    J Immunol; 2010 Jul; 185(1):698-708. PubMed ID: 20498356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
    Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
    Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen].
    Wong YQ; Qiu SJ; Tang ZY; Ye SL; Liu YK; Fan J; Sun RX; Zhao Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):339-42. PubMed ID: 15918966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma - from immunobiology to immunotherapy].
    Flecken T; Schmidt N; Spangenberg HC; Thimme R
    Z Gastroenterol; 2012 Jan; 50(1):47-56. PubMed ID: 22222798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.